Information Provided By:
Fly News Breaks for April 24, 2018
NUVA
Apr 24, 2018 | 08:06 EDT
Cowen analyst Joshua Jennings said NuVasive is a compelling long idea and he believes if Q12018 results repeat Q4 2017, it should be enough for the company to make its numbers. Jennings reiterated his Outperform rating and $62 price target on NuVasive shares, citing its compelling valuation, international strength, and U.S. organic growth rates.
News For NUVA From the Last 2 Days
There are no results for your query NUVA